Matthias Bodenstedt is Chief Financial Officer of MoonLake Immunotherapeutics. Currently has a direct ownership of 616,666 shares of MLTX, which is worth approximately $25.8 Million. The most recent transaction as insider was on Feb 27, 2025, when has been sold 95,763 shares (Class A ordinary shares, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 617K
18.38% 3M change
18.38% 12M change
Total Value Held $25.8 Million

Matthias Bodenstedt Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 27 2025
BUY
Grant, award, or other acquisition
-
95,763 Added 13.44%
616,666 Class A ordinary share...
Dec 20 2023
SELL
Open market or private sale
$307,101 $58.34 p/Share
5,264 Reduced 1.0%
520,903 Class A ordinary share...
Dec 19 2023
SELL
Open market or private sale
$5,610,265 $59.22 p/Share
94,736 Reduced 15.26%
526,167 Class A ordinary share...
Oct 01 2023
SELL
Sale (or disposition) back to the issuer
-
62,972 Reduced 17.62%
294,473 Class C ordinary share...
Oct 01 2023
BUY
Conversion of derivative security
-
62,972 Added 9.21%
620,903 Class A ordinary share...
Apr 05 2023
SELL
Sale (or disposition) back to the issuer
-
557,931 Reduced 60.95%
357,445 Class C ordinary share...
Apr 05 2023
BUY
Conversion of derivative security
-
557,931 Added 50.0%
557,931 Class A ordinary share...
MB

Matthias Bodenstedt

Chief Financial Officer
Zug, V8

Track Institutional and Insider Activities on MLTX

Follow MoonLake Immunotherapeutics and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MLTX shares.

Notify only if

Insider Trading

Get notified when an Moon Lake Immunotherapeutics insider buys or sells MLTX shares.

Notify only if

News

Receive news related to MoonLake Immunotherapeutics

Track Activities on MLTX